Wed, 25 March 2015
Can Amarin Corp Plc convert promise into profit? Motley Fool healthcare analyst Michael Douglass and healthcare contributor Todd Campbell discuss the challenges ahead for this volatile biotech stock. |
Categories
PodcastArchives
December
S | M | T | W | T | F | S |
---|---|---|---|---|---|---|
1 | 2 | |||||
3 | 4 | 5 | 6 | 7 | 8 | 9 |
10 | 11 | 12 | 13 | 14 | 15 | 16 |
17 | 18 | 19 | 20 | 21 | 22 | 23 |
24 | 25 | 26 | 27 | 28 | 29 | 30 |
31 |
Syndication
Wed, 25 March 2015
Can Amarin Corp Plc convert promise into profit? Motley Fool healthcare analyst Michael Douglass and healthcare contributor Todd Campbell discuss the challenges ahead for this volatile biotech stock. |